The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim results of a randomized phase 2 study of docetaxel with ramucirumab versus docetaxel in second-line advanced or metastatic urothelial carcinoma.
 
Daniel Peter Petrylak
Consulting or Advisory Role - Genentech; Lilly; Sanofi
Research Funding - Genentech; Lilly; Sanofi
Travel, Accommodations, Expenses - Genentech; Sanofi
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen; Astellas Pharma; Janssen; Lilly; Millennium/Prometrika; Progenics; Sanofi
 
Manish Kohli
No Relationships to Disclose
 
Shande Tang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Hui Zhang
Employment - Eisai; Lilly
 
Oday Hamid
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
John S. Kauh
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Richard A. Walgren
Employment - Lilly; Lilly (I)
Stock and Other Ownership Interests - Lilly; Pfizer (I)
 
Kim N. Chi
Consulting or Advisory Role - Lilly
Research Funding - Lilly